Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study

BACKGROUND: Topical treatments for atopic dermatitis (AD) used reactively often fail to achieve lasting disease control; many of these therapies are associated with safety concerns that limit long-term use. Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichenfield, Lawrence F., Gower, Richard G., Xu, JinHua, Alam, Maryam S., Su, John C., Myers, Daniela E., Sanders, Paul, Vlahos, Bonnie, Zang, Chuanbo, Lan, Jar, Werth, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184626/
https://www.ncbi.nlm.nih.gov/pubmed/37184828
http://dx.doi.org/10.1007/s40257-023-00780-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184626/
https://www.ncbi.nlm.nih.gov/pubmed/37184828
http://dx.doi.org/10.1007/s40257-023-00780-w

Ejemplares similares